These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6277983)

  • 1. Discrepancy between thyroid-stimulating and thyrotropin-binding inhibitory activities of Graves' immunoglobulin Gs assessed in the mouse.
    Shishiba Y; Ozawa Y; Ohtsuki N; Shimizu T
    J Clin Endocrinol Metab; 1982 Apr; 54(4):858-62. PubMed ID: 6277983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.
    Orgiazzi J; Williams DE; Chopra IJ; Solomon DH
    J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
    Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
    Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
    Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
    Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thyroid stimulators other than TSH. Classification. Immunoglobulins of Basedow's disease: history, methodology, nomenclature].
    Orgiazzi J; Madec AM
    Ann Endocrinol (Paris); 1982 Dec; 43(6):509-19. PubMed ID: 6134492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the mouse thyrotrophin receptor with thyrotrophin binding inhibitor immunoglobulins.
    Luttrell BM
    J Endocrinol; 1983 Mar; 96(3):481-8. PubMed ID: 6131925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin binding and long acting thyroid stimulator absorbing activities in subcellular fractions from isolated thyroid cells and thyroid homogenates.
    Mehdi SQ; Badger J; Kriss JP
    Endocrinology; 1977 Jul; 101(1):59-65. PubMed ID: 193685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG thyrotrophin receptor antibody activity in Graves' disease; a study of TSH agonist and antagonist activities by isoelectric focusing.
    Creagh FM; Howells RD; Williams S; Didcote S; Hashim FA; Petersen VB; Rees Smith B
    Clin Endocrinol (Oxf); 1986 Jan; 24(1):79-88. PubMed ID: 3011318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease.
    Shinozawa T; Villadolid MC; Ingbar SH
    J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.
    Fenzi G; Hashizume K; Roudebush CP; DeGroot LJ
    J Clin Endocrinol Metab; 1979 Apr; 48(4):572-6. PubMed ID: 581875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to the human thyrotropin receptor are not species specific.
    Davies TF
    J Clin Endocrinol Metab; 1981 Mar; 52(3):426-30. PubMed ID: 6257747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of LATS activity and TSH receptor antibody in Graves' disease.
    Kajita Y; Nakajima Y; Ishida M; Ura Y; Ochi Y; Miyazaki T; Hachiya T; Ijichi H
    Endocrinol Jpn; 1984 Jun; 31(3):369-74. PubMed ID: 6094169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients.
    Osuga Y; Liang SG; Dallas JS; Wang C; Hsueh AJ
    Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of TSH binding to chicken thyroid by some cases of LATS (long acting thyroid stimulator).
    Nakajima Y; Ishida M; Kajita Y; Ura Y; Ochi Y; Miyazaki T; Hachiya T; Ijichi H
    Endocrinol Jpn; 1986 Jun; 33(3):375-83. PubMed ID: 3019653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
    Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD
    J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the binding of Graves' immunoglobulins by the patients own and other thyroid membranes.
    Gossage AA; Byfield PG; Copping S; Himsworth RL
    Clin Endocrinol (Oxf); 1981 Mar; 14(3):301-10. PubMed ID: 6894892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay.
    Vitti P; Valente WA; Ambesi-Impiombato FS; Fenzi GF; Pinchera A; Kohn LD
    J Endocrinol Invest; 1982; 5(3):179-82. PubMed ID: 6286749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P; Harrison LC
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.
    Ginsberg J; von Westarp C
    CMAJ; 1986 May; 134(10):1141-7. PubMed ID: 2421862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.